Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

• DOI: 10.1016/j.ijid.2023.02.025
• Publication Date: 2023-03-08T01:45:52Z
• Authors: Joanitah Nalunjogi; Sergio Mucching-T...; Jean Pierre Sibomana; Rosella Centis; Lia D'Ambrosio; Jan-Willem Alffenaar; Justin Denholm; François-Xavier B...; Sergey Borisov; Edvardas Danila; Raquel Duarte; José-María García...; Delia Goletti; Catherine W.M. Ong; Adrian Rendon; Tania A. Thomas; Simon Tiberi; Martin van den Boom; Giovanni Sotgiu; Giovanni Battista...
• Keywords: Pandemic; Preparedness

ObjectivesAlthough evidence is growing on the overall impact of COVID-19 pandemic tuberculosis (TB) services, global studies based national data are needed to better quantify extent and countries' preparedness tackle two diseases. The aim this study was compare number people with new diagnoses or recurrence TB disease, drug-resistant (DR)-TB, deaths in 2020 vs 2019 11 countries Europe, Northern America, Australia.MethodsTB managers directors reference centers selected provided agreed-upon variables through a validated questionnaire monthly basis. A descriptive analysis compared incidence DR-TB mortality pre-COVID-19 year (2019) first (2020).ResultsComparing 2019, lower cases (new diagnosis recurrence) notified all (except USA-Virginia Australia), fewer notifications (apart from France, Portugal, Spain). among were higher most three (France, Netherlands, USA-Virginia) reporting minimal TB-related mortality.ConclusionsA comprehensive evaluation medium-term services would benefit similar multiple settings availability treatment outcome TB/COVID-19 co-infected patients.